Lupin Launches Generic OCD Capsules in U.S., an Industrial Info Market Brief
Lupin Launches Generic OCD Capsules in U.S., an Industrial Info Market Brief
Attachment: India Pharm 0219
Indian pharmaceutical major Lupin Limited announced its launch of the antidepressant drug clomipramine hydrochloride in the U.S. market, following approval from the U.S. Food and Drug Administration
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
